The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Counting the Costs of Drug-Related Adverse Events
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Incidence of Adverse Drug Events and Potential Adverse Drug Events: Implications for Prevention
Bates, D. W. (1995) · JAMA · doi:10.1001/jama.1995.03530010043033 · Cited by 2,127
A practical guide for calculating indirect costs of disease
Koopmanschap, M. A., & Rutten, F. F. H. (1996) · PharmacoEconomics · doi:10.2165/00019053-199610050-00003 · Cited by 358 · cited 1×
“Indirect costs may be defined as the value of production lost, more precisely as wealth lost, to society, as a result of disease and its treatment.[9] This should not be confused with the effects of inability to work on the well-being of the individual, which may be incorporated in the measurement of quality of life.”
Background
Cited by
Medication Use Leading to Emergency Department Visits for Adverse Drug Events in Older Adults
Budnitz, D. S., Shehab, N., Kegler, S. R., & Richards, C. L. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-11-200712040-00006 · Cited by 607
Clinical and economic burden of adverse drug reactions
Sultana, J., Cutroneo, P., & Trifirò, G. (2013) · Journal of Pharmacology and Pharmacotherapeutics · doi:10.4103/0976-500x.120957 · Cited by 528
Role of the pharmacist in reducing healthcare costs: current insights
Dalton, K., & Byrne, S. (2017) · Integrated Pharmacy Research and Practice · doi:10.2147/iprp.s108047 · Cited by 449
Medications safety pharmacoeconomics-related issues
Al-Worafi, Y. M. (2020) · Drug Safety in Developing Countries · doi:10.1016/b978-0-12-819837-7.00016-9 · Cited by 367
Yeboah-Korang, A., Memon, A., Patel, N., Portocarrero-Castillo, A., Osman, A., Kleesattel, D., Lopez, C., Louissaint, J., Sherman, K., & Fontana, R. (2022) · Digestive Diseases and Sciences · doi:10.1007/s10620-022-07403-0 · Cited by 5
Metadata
- Authors
- White, T. J., Arakelian, A., & Rho, J. P.
- Venue
- PharmacoEconomics
- Published
- 1999
- Volume
- 15
- Issue
- 5
- Pages
- 445-458
- ISSN
- 1170-7690 (ISSN-L)
- OpenAlex
- W2102802176
- Cited by
- 197
- References
- 2
- FWCI
- 9.53
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Counting the Costs of Drug-Related Adverse Events. https://app.cochat.ai/papers/10.2165/00019053-199915050-00003
- The paper
- White, T. J., Arakelian, A., & Rho, J. P. (1999). Counting the Costs of Drug-Related Adverse Events. PharmacoEconomics. https://doi.org/10.2165/00019053-199915050-00003
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.